Our motivation. Her eye disease.
To learn how Santen is
advancing the ophthalmic fi eld,
scan this code with your mobile
device or visit www.santeninc.com.
Image is designed to represent nondescript visual impairment and is not
intended to be medically accurate. For illustrative purposes only.
© 2013 Santen Pharmaceutical Co., Ltd. All rights reserved. SAN-269.00 07/12
At Santen, our single focus in ophthalmology enables
research of novel therapies in uveitis, glaucoma, and
dry eye/corneal disorders—therapies determined to
challenge eye disease, one patient at a time.
Inspiring ophthalmic medicines
